Neoadjuvant pembrolizumab+chemotherapy/adjuvant pembrolizumab for Early-Stage Triple-Negative breast cancer: Quality-of-Life results from randomized KEYNOTE-522 study.

Rebecca A DentJavier CortésLajos PusztaiHeather McArthurSherko KümmelJonas BerghCarsten DenkertYeon Hee ParkRina HuiNadia HarbeckMasato TakahashiMichael UntchPeter A FaschingFatima CardosoAmin HaideraliLiyi JiaAllison Martin NguyenWilbur PanJoyce O'ShaughnessyPeter Schmid

Published in: Journal of the National Cancer Institute (2024)

ClinicalTrials.gov, NCT03036488.

Keyphrases

early stage
locally advanced
advanced non small cell lung cancer
phase ii
rectal cancer
double blind
open label
lymph node
clinical trial
placebo controlled
sentinel lymph node
phase iii
randomized controlled trial
radiation therapy
neoadjuvant chemotherapy
epidermal growth factor receptor